Ranbaxy in pact with Swiss company.

Economic Times (New Delhi, India), January, 2006

Jan. 11--DELHI -- Ranbaxy on Tuesday announced a co-marketing agreement with Ferring International of Switzerland, a speciality biopharmaceutical company, for the latter's hormone tablet Desmopressin in India. Desmopressin, a structural analogue of the pituitary hormone Arginine Vasopressin, is used to treat Nocturia, a condition seen in paediatric and geriatric patients. The Swiss company markets Desmopressin, its own original research product, through its Indian subsidiary.

A Ranbaxy statement said the new co-marketing arrangement aims to leverage the company's significant marketing and distribution strengths to maximise patient coverage within the country. The product will be sold under the brandname Adiuretin. The company statement, however, did not give...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here